Innate Pharma S.A. - stock earnings
IPHA Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q2 | 1.9 million USD | 38.4 million USD |
2023Q1 | -70.2 million USD | 9.1 million USD |
2022Q4 | 921854 USD | 21.6 million USD |
2022Q3 | -31.6 million USD | 5.9 million USD |
2022Q2 | 3.2 million USD | 22.8 million USD |
2022Q1 | 3.2 million USD | 22.8 million USD |
2021Q2 | -11.9 million EUR | 7.8 million EUR |
2021Q1 | -11.9 million EUR | 7.8 million EUR |
2020Q4 | -26.8 million EUR | 16.9 million EUR |
2020Q3 | -26.8 million EUR | 16.9 million EUR |
2020Q2 | -5.8 million USD | 20.6 million USD |
2020Q1 | ? USD | 20.3 million USD |
2019Q4 | -75.2 million USD | 58.9 million USD |
2019Q3 | -52.3 million USD | 41.0 million USD |
2019Q2 | 32.1 million USD | 143.6 million USD |
2019Q1 | 29.4 million USD | 131.3 million USD |
2018Q4 | 12.6 million USD | 46.1 million USD |
2018Q3 | 13.0 million USD | 47.3 million USD |
IPHA Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2022 | -106.4 million USD | 53.3 million USD |
2021 | -67.3 million USD | 13.8 million USD |
2020 | -86.2 million USD | 69.2 million USD |
2019 | -23.5 million USD | 77.3 million USD |
2018 | 3.5 million USD | 91.4 million USD |
2017 | -57.8 million USD | 39.0 million USD |
2016 | 13.3 million USD | 59.1 million USD |
2015 | -7.3 million USD | 19.6 million USD |
2014 | -23.9 million USD | 1.1 million USD |
2013 | -4.0 million USD | 17.2 million USD |
2012 | -4.2 million USD | 13.7 million USD |
2011 | -9.0 million USD | 15.2 million USD |
2010 | -18.2 million USD | 5.7 million USD |
2009 | -21.0 million USD | 11.1 million USD |
2008 | -13.7 million USD | 18.0 million USD |
2007 | -13.0 million USD | 20.9 million USD |
2006 | -8.0 million USD | 8.2 million USD |
2005 | -7.3 million USD | 1.5 million USD |
IPHA
Price: $2.49
52 week price:
Earnings Per Share: -0.10 USD
P/E Ratio: -3.06
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 6529
Market Capitalization: 205.8 million